The contribution of small airway obstruction to the pathogenesis of chronic obstructive pulmonary disease

Physiological Reviews

Volumn 97, Issue 2, 2017, Pages 529-552

  Hogg, James C ^a,b   Paré, Peter D ^a,b   Hackett, Tillie Louise ^a,b  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NITROGEN;

AIRWAY OBSTRUCTION; ARTICLE; BREATH ANALYSIS; BREATHING; CHRONIC OBSTRUCTIVE LUNG DISEASE; GAS TRANSPORT; HUMAN; IMAGING; INFLAMMATION; LUNG; LUNG FLOW VOLUME CURVE; MUCUS SECRETION; NITROGEN WASHOUT; OSCILLATION; PARTICULATE MATTER; PATHOGENESIS; PRIORITY JOURNAL; RESPIRATORY EPITHELIUM; RESPIRATORY SYSTEM; RESPIRATORY TRACT DISEASE; SMOKING; ANIMAL; COMPLICATION; EARLY DIAGNOSIS; LUNG EMPHYSEMA; PATHOLOGY; PROCEDURES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; X-RAY COMPUTED TOMOGRAPHY;

AIRWAY OBSTRUCTION; ANIMALS; EARLY DIAGNOSIS; HUMANS; LUNG; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; PULMONARY EMPHYSEMA; TOMOGRAPHY, X-RAY COMPUTED;

EID: 85011320152     PISSN: 00319333     EISSN: 15221210     Source Type: Journal    
DOI: 10.1152/physrev.00025.2015     Document Type: Article

References (141)

1. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nature Rev Immunol 6: 205-217, 2006.
2. Baraldo S, Turato G, Lunardi F, Bazzan E, Schiavon M, Ferrarotti I, Molena B, Cazzuffi R, Damin M, Balestro E, Luisetti M, Rea F, Calabrese F, Cosio MG, Saetta M. Immune activation in alpha1-antitrypsin-deficiency emphysema. Beyond the protease-antiprotease paradigm. Am J Respir Crit Care Med 191: 402-409, 2015.
3. Barnes PJ, Adcock IM, Ito K. Histone acetylation and deacetylation: importance in inflammatory lung diseases. Eur Respir J 25: 552-563, 2005.
4. Becker S, Mundandhara S, Devlin RB, Madden M. Regulation of cytokine production in human alveolar macrophages and airway epithelial cells in response to ambient air pollution particles: further mechanistic studies. Toxicol Appl Pharmacol 207: 269-275, 2005.
5. Bernink JH, Peters CP, Munneke M, te Velde AA, Meijer SL, Weijer K, Hreggvidsdottir HS, Heinsbroek SE, Legrand N, Buskens CJ, Bemelman WA, Mjosberg JM, Spits H. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nature Immunol 14: 221-229, 2013.
6. Boes JL, Hoff BA, Bule M, Johnson TD, Rehemtulla A, Chamberlain R, Hoffman EA, Kazerooni EA, Martinez FJ, Han MK, Ross BD, Galban CJ. Parametric response mapping monitors temporal changes on lung CT scans in the subpopulations and intermediate outcome measures in COPD Study (SPIROMICS). Academic Radiol 22: 186-194, 2015.
7. Boon M, Verleden SE, Bosch B, Lammertyn E, McDonough JE, Mai C, Verschakelen J, Kemner-van de Corput M, Tiddens H, Proesmans M, Vermeulen FL, Verbeken EK, Cooper J, Decramer M, Verleden GM, Hogg JC, Vanaudenaerde BM, Dupont LJ, De Boeck K. Morphometric analysis of explant lungs in cystic fibrosis. Am J Respir Cell Mol Biol 193: 516-526, 2016.
8. Borgerding M, Klus H. Analysis of complex mixtures-cigarette smoke. Exp Toxicol Pathol 57 Suppl 1: 43-73, 2005.
9. Brusselle GG, Demoor T, Bracke KR, Brandsma CA, Timens W. Lymphoid follicles in (very) severe COPD: beneficial or harmful? Eur Respir J 34: 219-230, 2009.
10. Buist AS, Ghezzo H, Anthonisen NR, Cherniack RM, Ducic S, Macklem PT, Manfreda J, Martin RR, McCarthy D, Ross BB. Relationship between the single-breathNtest and age, sex, and smoking habit in three North American cities. Am Rev Respir Dis 120: 305-318, 1979.
11. Buist AS, Vollmer WM, Johnson LR, McCamant LE. Does the single-breath N2 test identify the smoker who will develop chronic airflow limitation? Am Rev Respir Dis 137: 293-301, 1988.
12. Buonocore S, Ahern PP, Uhlig HH, Ivanov II, Littman DR, Maloy KJ, Powrie F. Innate lymphoid cells drive interleukin-23-dependent innate intestinal pathology. Nature 464: 1371-1375, 2010.
13. Burgel PR, Nadel JA. Roles of epidermal growth factor receptor activation in epithelial cell repair and mucin production in airway epithelium. Thorax 59: 992-996, 2004.
14. Campbell JD, McDonough JE, Zeskind JE, Hackett TL, Pechkovsky DV, Brandsma CA, Suzuki M, Gosselink JV, Liu G, Alekseyev YO, Xiao J, Zhang X, Hayashi S, Cooper JD, Timens W, Postma DS, Knight DA, Lenburg ME, Hogg JC, Spira A. A gene expression signature of emphysema-related lung destruction and its reversal by the tripeptide GHK. Genome Med 4: 67, 2012.
15. Carnevali S, Nakamura Y, Mio T, Liu X, Takigawa K, Romberger DJ, Spurzem JR, Rennard SI. Cigarette smoke extract inhibits fibroblast-mediated collagen gel contraction. Am J Physiol Lung Cell Mol Physiol 274: L591-L598, 1998.
16. Carnevali S, Petruzzelli S, Longoni B, Vanacore R, Barale R, Cipollini M, Scatena F, Paggiaro P, Celi A, Giuntini C. Cigarette smoke extract induces oxidative stress and apoptosis in human lung fibroblasts. Am J Physiol Lung Cell Mol Physiol 284: L955-L963, 2003.
17. Cone RA. Barrier properties of mucus. Adv Drug Delivery Rev 61: 75-85, 2009.
18. Cosio M, Ghezzo H, Hogg JC, Corbin R, Loveland M, Dosman J, Macklem PT. The relations between structural changes in small airways and pulmonary-function tests. N Engl J Med 298: 1277-1281, 1978.
19. Cosio MG, Hale KA, Niewoehner DE. Morphologic and morphometric effects of prolonged cigarette smoking on the small airways. Am Rev Respir Dis 122: 265-221, 1980.
20. De Grove KC, Provoost S, Verhamme FM, Bracke KR, Joos GF, Maes T, Brusselle GG. Characterization and quantification of innate lymphoid cell subsets in human lung. PloS One 11: e0145961, 2016.
21. Dellaca RL, Santus P, Aliverti A, Stevenson N, Centanni S, Macklem PT, Pedotti A, Calverley PM. Detection of expiratory flow limitation in COPD using the forced oscillation technique. Eur Respir J 23: 232-240, 2004.
22. Derdak S, Mehta S, Stewart TE, Smith T, Rogers M, Buchman TG, Carlin B, Lowson S, Granton J, Multicenter Oscillatory Ventilation For Acute Respiratory Distress Syndrome Trial Study I. High-frequency oscillatory ventilation for acute respiratory distress syndrome in adults: a randomized, controlled trial. Am J Respir Crit Care Med 166: 801-808, 2002.
23. Deshmukh HS, Shaver C, Case LM, Dietsch M, Wesselkamper SC, Hardie WD, Korfhagen TR, Corradi M, Nadel JA, Borchers MT, Leikauf GD. Acrolein-activated matrix metalloproteinase 9 contributes to persistent mucin production. Am J Respir Cell Mol Biol 38: 446-454, 2008.
24. Detels R, Tashkin DP, Simmons MS, Carmichael HE Jr, Sayre JW, Rokaw SN, Coulson AH Sayre JW, Rokaw SN, Coulson AH. The UCLA population studies of chronic obstructive respiratory disease 5 Agreement and disagreement of tests in identifying abnormal lung function. Chest 82: 630-638, 1982.
25. Dollfuss RE, Milic-Emili J, Bates DV. Regional ventilation of the lung, studied with boluses of 133Xenon. Respir Physiol 2: 234-246, 1967.
26. Dosman JA, Cotton DJ, Graham BL, Hall DL, Li R, Froh F, Barnett GD. Sensitivity and specificity of early diagnostic tests of lung function in smokers. Chest 79: 6-11, 1981.
27. Dubois AB. Resistance to Breathing. Baltimore, MD: Williams and Wilkins, 1964.
28. Dubois AB, Botelho SY, Comroe JH Jr. A new method for measuring airway resistance in man using a body plethysmograph: values in normal subjects and in patients with respiratory disease. J Clin Invest 35: 327-335, 1956.
29. Dubois AB, Brody AW, Lewis DH, Burgess BF Jr. Oscillation mechanics of lungs and chest in man. J Appl Physiol 8: 587-594, 1956.
30. Eberl G. Development and evolution of RORgammat+ cells in a microbe’s world. Immunol Rev 245: 177-188, 2012.
31. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med 363: 2233-2247, 2010.
32. Farrow CE, Salome CM, Harris BE, Bailey DL, Bailey E, Berend N, Young IH, King GG. Airway closure on imaging relates to airway hyperresponsiveness and peripheral airway disease in asthma. J Appl Physiol (1985) 113: 958-966, 2012.
33. Finkelstein R, Fraser RS, Ghezzo H, Cosio MG. Alveolar inflammation and its relation to emphysema in smokers. Am J Respir Crit Care Med 152: 1666-1672, 1995.
34. Fletcher CM, Peto R, Tinker C, Speizer FE. The Natural History of Chronic Bronchitis and Emphysema. Oxford, UK: Oxford Univ. Press, 1976, p. 150.
35. Fletcher CM. Letter: Natural history of chronic bronchitis. Br Med J 1: 1592-1593, 1976.
36. Fredberg JJ, Keefe DH, Glass GM, Castile RG, Frantz ID 3rd. Alveolar pressure nonhomogeneity during small-amplitude high-frequency oscillation. J Appl Physiol 57: 788-800, 1984.
37. Fuchs A, Vermi W, Lee JS, Lonardi S, Gilfillan S, Newberry RD, Cella M, Colonna M. Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12-and IL-15-responsive IFN-gamma-producing cells. Immunity 38: 769-781, 2013.
38. Galban CJ, Han MK, Boes JL, Chughtai KA, Meyer CR, Johnson TD, Galban S, Rehemtulla A, Kazerooni EA, Martinez FJ, Ross BD. Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nature Med 18: 1711-1715, 2012.
39. Green M. How big are the bronchioles? In: St. Thomas Hospital Gazette. London: St. Thomas’s Hospital, 1965, p. 136.1711-139
40. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare PD. The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350: 2645-2653, 2004.
41. Hogg JC, Macklem PT, Thurlbeck WM. The resistance of small airways in normal and diseased human lungs. Aspen Emphysema Conf 10: 433-441, 1967.
42. Hogg JC, Macklem PT, Thurlbeck WM. Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278: 1355-1360, 1968.
43. Hogg JC, McDonough JE, Suzuki M. Small airway obstruction in COPD: new insights based on micro-CT imaging and MRI imaging. Chest 143: 1436-1443, 2013.
44. Hogg JC, Timens W. The pathology of chronic obstructive pulmonary disease. Annu Rev Pathol 4: 435-459, 2009.
45. Hogg JC, Williams J, Richardson JB, Macklem PT, Thurlbeck WM. Age as a factor in the distribution of lower-airway conductance and in the pathologic anatomy of obstructive lung disease. N Engl J Med 282: 1283-1287, 1970.
46. Horsfield K, Cumming G. Morphology of the bronchial tree in man. J Appl Physiol 24: 373-383, 1968.
47. Ito K, Ito M, Elliott WM, Cosio B, Caramori G, Kon OM, Barczyk A, Hayashi S, Adcock IM, Hogg JC, Barnes PJ. Decreased histone deacetylase activity in chronic obstructive pulmonary disease. N Engl J Med 352: 1967-1976, 2005.
48. Jeffery PK. Structural and inflammatory changes in COPD: a comparison with asthma. Thorax 53: 129-136, 1998.
49. Johnston RN, McNeill RS, Smith DH, Legge JS, Fletcher F. Chronic bronchitis-measurements and observations over 10 years. Thorax 31: 25-29, 1976.
50. Kearley J, Silver JS, Sanden C, Liu Z, Berlin AA, White N, Mori M, Pham TH, Ward CK, Criner GJ, Marchetti N, Mustelin T, Erjefalt JS, Kolbeck R, Humbles AA. Cigarette smoke silences innate lymphoid cell function and facilitates an exacerbated type I interleukin-33-dependent response to infection. Immunity 42: 566-579, 2015.
51. King GG. Cutting edge technologies in respiratory research: lung function testing. Respirology 16: 883-890, 2011.
52. King GG, Downie SR, Verbanck S, Thorpe CW, Berend N, Salome CM, Thompson B. Effects of methacholine on small airway function measured by forced oscillation technique and multiple breath nitrogen washout in normal subjects. Respir Physiol Neurobiol 148: 165-177, 2005.
53. Koo HK, Vasilescu DM, Scott AE, Orestis K, Warner JA, Sinclair I, Hogg JC, Hackett TL. Micro-CT analysis of paraffin embedded lung tissue: is small airway obstruction an early feature Of COPD? Am J Respir Crit Care Med 191: A5573, 2015.
54. Lai SK, Wang YY, Wirtz D, Hanes J. Micro-and macrorheology of mucus. Adv Drug Delivery Rev 61: 86-100, 2009.
55. Lange P, Celli B, Agusti A, Boje Jensen G, Divo M, Faner R, Guerra S, Marott JL, Martinez FD, Martinez-Camblor P, Meek P, Owen CA, Petersen H, Pinto-Plata V, Schnohr P, Sood A, Soriano JB, Tesfaigzi Y, Vestbo J. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 373: 111-122, 2015.
56. Larsson L, Szponar B, Ridha B, Pehrson C, Dutkiewicz J, Krysinska-Traczyk E, Sitkowska J. Identification of bacterial and fungal components in tobacco and tobacco smoke. Tobacco Induced Dis 4: 4, 2008.
57. Larsson-Callerfelt AK, Hallgren O, Andersson-Sjoland A, Thiman L, Bjorklund J, Kron J, Nihlberg K, Bjermer L, Lofdahl CG, Westergren-Thorsson G. Defective alterations in the collagen network to prostacyclin in COPD lung fibroblasts. Respir Res 14: 21, 2013.
58. Leopold PL, O’Mahony MJ, Lian XJ, Tilley AE, Harvey BG, Crystal RG. Smoking is associated with shortened airway cilia. PloS One 4: e8157, 2009.
59. Levine G, Housley E, MacLeod P, Macklem PT. Gas exchange abnormalities in mild bronchitis and asymptomatic asthma. N Engl J Med 282: 1277-1282, 1970.
60. Lozewicz S, Wells C, Gomez E, Ferguson H, Richman P, Devalia J, Davies RJ. Morphological integrity of the bronchial epithelium in mild asthma. Thorax 45: 12-15, 1990.
61. Lutchen KR, Gillis H. Relationship between heterogeneous changes in airway morphometry and lung resistance and elastance. J Appl Physiol (1985) 83: 1192-1201, 1997.
62. Macklem PT, Mead J. Resistance of central and peripheral airways measured by a retrograde catheter. J Appl Physiol 22: 395-401, 1967.
63. Mallia P, Message SD, Gielen V, Contoli M, Gray K, Kebadze T, Aniscenko J, Laza-Stanca V, Edwards MR, Slater L, Papi A, Stanciu LA, Kon OM, Johnson M, Johnston SL. Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation. Am J Respir Crit Care Med 183: 734-742, 2011.
64. McDonough JE, Yuan R, Suzuki M, Seyednejad N, Elliott WM, Sanchez PG, Wright AC, Gefter WB, Litzky L, Coxson HO, Pare PD, Sin DD, Pierce RA, Woods JC, McWilliams AM, Mayo JR, Lam SC, Cooper JD, Hogg JC. Small-airway obstruction and emphysema in chronic obstructive pulmonary disease. N Engl J Med 365: 1567-1575, 2011.
65. Mead J. The lung’s “quiet zone.” N Engl J Med 282: 1318-1319, 1970.
66. Mebius RE, Rennert P, Weissman IL. Developing lymph nodes collect CD4+CD3-LTbeta+ cells that can differentiate to APC, NK cells, and follicular cells but not T or B cells. Immunity 7: 493-504, 1997.
67. Mitzner W. Emphysema-a disease of small airways or lung parenchyma? N Engl J Med 365: 1637-1639, 2011.
68. Mjosberg JM, Trifari S, Crellin NK, Peters CP, van Drunen CM, Piet B, Fokkens WJ, Cupedo T, Spits H. Human IL-25-and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD 161. Nature Immunol 12: 1055-1062, 2011.
69. Moro K, Yamada T, Tanabe M, Takeuchi T, Ikawa T, Kawamoto H, Furusawa J, Ohtani M, Fujii H, Koyasu S. Innate production of T(H)2 cytokines by adipose tissueassociated c-Kit(+)Sca-1(+) lymphoid cells. Nature 463: 540-544, 2010.
70. Mullen JB, Wright JL, Wiggs BR, Pare PD, Hogg JC. Reassessment of inflammation of airways in chronic bronchitis. Br Med J 291: 1235-1239, 1985.
71. Murphy TF, Brauer AL, Eschberger K, Lobbins P, Grove L, Cai X, Sethi S. Pseudomonas aeruginosa in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 853-860, 2008.
72. Murphy TF, Brauer AL, Grant BJ, Sethi S. Moraxella catarrhalis in chronic obstructive pulmonary disease: burden of disease and immune response. Am J Respir Crit Care Med 172: 195-199, 2005.
73. Murphy TF, Brauer AL, Schiffmacher AT, Sethi S. Persistent colonization by Haemophilus influenzae in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 170: 266-272, 2004.
74. Murtagh PS, Proctor DF, Permutt S, Kelly BL, Evering S. Bronchial mechanics in excised dog lobes. J Appl Physiol 31: 403-408, 1971.
75. Nagaishi C. Functional Anatomy and Histology of the Lung. Baltimore: University Park Press, 1972.
76. Nakamura Y, Romberger DJ, Tate L, Ertl RF, Kawamoto M, Adachi Y, Mio T, Sisson JH, Spurzem JR, Rennard SI. Cigarette smoke inhibits lung fibroblast proliferation and chemotaxis. Am J Respir Crit Care Med 151: 1497-1503, 1995.
77. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, Coxson HO, Elliott WM, Hogg JC, Pare PD. The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 171: 142-146, 2005.
78. Neill DR, Wong SH, Bellosi A, Flynn RJ, Daly M, Langford TK, Bucks C, Kane CM, Fallon PG, Pannell R, Jolin HE, McKenzie AN. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature 464: 1367-1370, 2010.
79. Nemery B, Moavero NE, Brasseur L, Stanescu DC. Significance of small airway tests in middle-aged smokers. Am Rev Respir Dis 124: 232-238, 1981.
80. Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respirator therapy of hyaline-membrane disease bronchopulmonary dysplasia. N Engl J Med 276: 357-368, 1967.
81. Olofsson J, Bake B, Svardsudd K, Skoogh BE. The single breath N2-test predicts the rate of decline in FEV1. The study of men born in 1913 and 1923. Eur J Respir Dis 69: 46-56, 1986.
82. Oppenheimer BW, Goldring RM, Berger KI. Distal airway function assessed by oscillometry at varying respiratory rate: comparison with dynamic compliance. COPD 6: 162-170, 2009.
83. Pare PD, Brooks LA, Coppin CA, Wright JL, Kennedy S, Dahlby R, Mink S, Hogg JC. Density-dependence of maximal expiratory flow and its correlation with small airway disease in smokers. Am Rev Respir Dis 131: 521-526, 1985.
84. Pauly JL, Smith LA, Rickert MH, Hutson A, Paszkiewicz GM. Review: is lung inflammation associated with microbes and microbial toxins in cigarette tobacco smoke? Immunol Res 46: 127-136, 2010.
85. Polverino F, Baraldo S, Bazzan E, Agostini S, Turato G, Lunardi F, Balestro E, Damin M, Papi A, Maestrelli P, Calabrese F, Saetta M. A novel insight into adaptive immunity in chronic obstructive pulmonary disease: B cell activating factor belonging to the tumor necrosis factor family. Am J Respir Crit Care Med 182: 1011-1019, 2010.
86. Price AE, Liang HE, Sullivan BM, Reinhardt RL, Eisley CJ, Erle DJ, Locksley RM. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc Natl Acad Sci USA 107: 11489-11494, 2010.
87. Pryor WA, Stone K. Oxidants in cigarette smoke. Radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite. Ann NY Acad Sci 686: 12-27, 1993.
88. Rahman I. Oxidative stress in pathogenesis of chronic obstructive pulmonary disease: cellular and molecular mechanisms. Cell Biochem Biophys 43: 167-188, 2005.
89. Rahman I, Marwick J, Kirkham P. Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-kappaB and pro-inflammatory gene expression. Biochem Pharmacol 68: 1255-1267, 2004.
90. Randall TD. Bronchus-Associated Lymphoid Tissue (BALT): Structure and Function. Rochester, NY: Elsevier, 2010.
91. Regan EA, Hokanson JE, Murphy JR, Make B, Lynch DA, Beaty TH, Curran-Everett D, Silverman EK, Crapo JD. Genetic epidemiology of COPD (COPDGene) study design. COPD 7: 32-43, 2010.
92. Reid L. The secondary lobule in the adult human lung, with special reference to its appearance in bronchograms. Thorax 13: 110-115, 1958.
93. Roher F. Der Stromungswiderstand in der menschlichen Atemwegen und der Einfluss der unregelmassigen Verzweigung es Bronchial-systems auf der Atmungsverlauf in vershiedenen Lungenbezinken. Arch Ges Physiol 162: 225-229, 1915.
94. Rohrer F. Physiologie der Atembewegung. Berlin, Germany: Springer, 1925.
95. Rossoff LJ, Csima A, Zamel N. Reproducibility of maximum expiratory flow in severe chronic obstructive pulmonary disease. Bull Eur Physiopathol Respir 15: 1129-1136, 1979.
96. Saetta M, Di Stefano A, Maestrelli P, Ferraresso A, Drigo R, Potena A, Ciaccia A, Fabbri LM. Activated T-lymphocytes and macrophages in bronchial mucosa of subjects with chronic bronchitis. Am Rev Respir Dis 147: 301-306, 1993.
97. Saetta M, Di Stefano A, Turato G, Facchini FM, Corbino L, Mapp CE, Maestrelli P, Ciaccia A, Fabbri LM. CD8+ T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 822-826, 1998.
98. Saetta M, Turato G, Baraldo S, Zanin A, Braccioni F, Mapp CE, Maestrelli P, Cavallesco G, Papi A, Fabbri LM. Goblet cell hyperplasia and epithelial inflammation in peripheral airways of smokers with both symptoms of chronic bronchitis and chronic airflow limitation. Am J Respir Crit Care Med 161: 1016-1021, 2000.
99. Saetta M, Turato G, Facchini FM, Corbino L, Lucchini RE, Casoni G, Maestrelli P, Mapp CE, Ciaccia A, Fabbri LM. Inflammatory cells in the bronchial glands of smokers with chronic bronchitis. Am J Respir Crit Care Med 156: 1633-1639, 1997.
100. Sakai M, Sato Y, Sato S, Ihara S, Onizuka M, Sakakibara Y, Takahashi H. Effect of relocating to areas of reduced atmospheric particulate matter levels on the human circulating leukocyte count. J Appl Physiol (1985) 97: 1774-1780, 2004.
101. Salimi M, Barlow JL, Saunders SP, Xue L, Gutowska-Owsiak D, Wang X, Huang LC, Johnson D, Scanlon ST, McKenzie AN, Fallon PG, Ogg GS. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med 210: 2939-2950, 2013.
102. Sanjuan MA, Dillon CP, Tait SW, Moshiach S, Dorsey F, Connell S, Komatsu M, Tanaka K, Cleveland JL, Withoff S, Green DR. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450: 1253-1257, 2007.
103. Sapkota AR, Berger S, Vogel TM. Human pathogens abundant in the bacterial metagenome of cigarettes. Environ Health Perspect 118: 351-356, 2010.
104. Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med 359: 2355-2365, 2008.
105. Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJ, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest 118: 1557-1565, 2000.
106. Singh M, Lee SH, Porter P, Xu C, Ohno A, Atmar RL, Greenberg SB, Bandi V, Gern J, Amineva S, Aminev A, Skern T, Smithwick P, Perusich S, Barrow N, Roberts L, Corry DB, Kheradmand F. Human rhinovirus proteinase 2A induces TH1 and TH2 immunity in patients with chronic obstructive pulmonary disease. J Allergy Clin Immunol 125: 1369-1378 e1362, 2010.
107. Solomon DA. Are small airways tests helpful in the detection of early airflow obstruction? Chest 74: 567-569, 1978.
108. Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, Locksley RM, McKenzie AN, Mebius RE, Powrie F, Vivier E. Innate lymphoid cells-a proposal for uniform nomenclature. Nature Rev Immunol 13: 145-149, 2013.
109. Spits H, Di Santo JP. The expanding family of innate lymphoid cells: regulators and effectors of immunity and tissue remodeling. Nature Immunol 12: 21-27, 2011.
110. Stone PJ, Morris SM, Thomas KM, Schuhwerk K, Mitchelson A. Repair of elastasedigested elastic fibers in acellular matrices by replating with neonatal rat-lung lipid interstitial fibroblasts or other elastogenic cell types. Am J Respir Cell Mol Biol 17: 289-301, 1997.
111. Suzuki M, Elliott WM, McDonough JE, Hayashi S, Sanchez PG, Cooper JD, Hogg JC. The quantitative relationship between collagen deposition and lung structure in COPD (Abstract). Am J Respir Cell Mol Biol 181: A6808, 2010.
112. Svanes C, Sunyer J, Plana E, Dharmage S, Heinrich J, Jarvis D, de Marco R, Norback D, Raherison C, Villani S, Wjst M, Svanes K, Anto JM. Early life origins of chronic obstructive pulmonary disease. Thorax 65: 14-20, 2010.
113. Takeyama K, Jung B, Shim JJ, Burgel PR, Dao-Pick T, Ueki IF, Protin U, Kroschel P, Nadel JA. Activation of epidermal growth factor receptors is responsible for mucin synthesis induced by cigarette smoke. Am J Physiol Lung Cell Mol Physiol 280: L165-L172, 2001.
114. Tamashiro E, Xiong G, Anselmo-Lima WT, Kreindler JL, Palmer JN, Cohen NA. Cigarette smoke exposure impairs respiratory epithelial ciliogenesis. Am J Rhinol Allergy 23: 117-122, 2009.
115. Tan WC, Qiu D, Liam BL, Ng TP, Lee SH, van Eeden SF, D’Yachkova Y, Hogg JC. The human bone marrow response to acute air pollution caused by forest fires. Am J Respir Crit Care Med 161: 1213-1217, 2000.
116. Tanabe N, Vasilescu DM, McDonough JE, Kinose D, Suzuki M, Cooper JD, Pare PD, Hogg JC. MicroCT comparison of preterminal bronchioles in centrilobular and panlobular emphysema. Am J Respir Crit Care Med. In press.
117. Terry PB, Traystman RJ, Newball HH, Batra G, Menkes HA. Collateral ventilation in man. N Engl J Med 298: 10-15, 1978.
118. Thornton DJ, Sheehan JK. From mucins to mucus: toward a more coherent understanding of this essential barrier. Proc Am Thoracic Soc 1: 54-61, 2004.
119. Tiddens HA, Pare PD, Hogg JC, Hop WC, Lambert R, de Jongste JC. Cartilaginous airway dimensions and airflow obstruction in human lungs. Am J Respir Crit Care Med 152: 260-266, 1995.
120. Togo S, Holz O, Liu X, Sugiura H, Kamio K, Wang X, Kawasaki S, Ahn Y, Fredriksson K, Skold CM, Mueller KC, Branscheid D, Welker L, Watz H, Magnussen H, Rennard SI. Lung fibroblast repair functions in patients with chronic obstructive pulmonary disease are altered by multiple mechanisms. Am J Respir Crit Care Med 178: 248-260, 2008.
121. Van Brabandt H, Cauberghs M, Verbeken E, Moerman P, Lauweryns JM, Van de Woestijne KP. Partitioning of pulmonary impedance in excised human and canine lungs. J Appl Physiol 55: 1733-1742, 1983.
122. Van der Strate BW, Postma DS, Brandsma CA, Melgert BN, Luinge MA, Geerlings M, Hylkema MN, van den Berg A, Timens W, Kerstjens HA. Cigarette smoke-induced emphysema: a role for the B cell? Am J Respir Crit Care Med 173: 751-758, 2006.
123. Van Eeden SF, Tan WC, Suwa T, Mukae H, Terashima T, Fujii T, Qui D, Vincent R, Hogg JC. Cytokines involved in the systemic inflammatory response induced by exposure to particulate matter air pollutants [PM(10)]. Am J Respir Crit Care Med 164: 826-830, 2001.
124. Verbanck S, Schuermans D, Meysman M, Paiva M, Vincken W. Noninvasive assessment of airway alterations in smokers: the small airways revisited. Am J Respir Crit Care Med 170: 414-419, 2004.
125. Verbanck S, Schuermans D, Noppen M, Van Muylem A, Paiva M, Vincken W. Evidence of acinar airway involvement in asthma. Am J Respir Crit Care Med 159: 1545-1550, 1999.
126. Verbanck S, Schuermans D, Paiva M, Meysman M, Vincken W. Small airway function improvement after smoking cessation in smokers without airway obstruction. Am J Respir Crit Care Med 174: 853-857, 2006.
127. Verbanck S, Schuermans D, Van Muylem A, Melot C, Noppen M, Vincken W, Paiva M. Conductive and acinar lung-zone contributions to ventilation inhomogeneity in COPD. Am J Respir Crit Care Med 157: 1573-1577, 1998.
128. Verbanck S, Schuermans D, Van Muylem A, Paiva M, Noppen M, Vincken W. Ventilation distribution during histamine provocation. J Appl Physiol (1985) 83: 1907-1916, 1997.
129. Verleden SE, Vasilescu DM, Willems S, Ruttens D, Vos R, Vandermeulen E, Hostens J, McDonough JE, Verbeken EK, Verschakelen J, Van Raemdonck DE, Rondelet B, Knoop C, Decramer M, Cooper J, Hogg JC, Verleden GM, Vanaudenaerde BM. The site and nature of airway obstruction after lung transplantation. Am J Respir Crit Care Med 189: 292-300, 2014.
130. Verra F, Escudier E, Lebargy F, Bernaudin JF, De Cremoux H, Bignon J. Ciliary abnormalities in bronchial epithelium of smokers, ex-smokers, and nonsmokers. Am J Respir Crit Care Med 151: 630-634, 1995.
131. Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera GK, Chapman A, Smith CH, Di Meglio P, Nestle FO. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ILC3 in psoriasis. J Invest Dermatol 134: 984-991, 2014.
132. Vlahovic G, Russell ML, Mercer RR, Crapo JD. Cellular and connective tissue changes in alveolar septal walls in emphysema. Am J Respir Crit Care Med 160: 2086-2092, 1999.
133. Wagner EM, Bleecker ER, Permutt S, Liu MC. Direct assessment of small airways reactivity in human subjects. Am J Respir Crit Care Med 157: 447-452, 1998.
134. Wagner EM, Liu MC, Weinmann GG, Permutt S, Bleecker ER. Peripheral lung resistance in normal and asthmatic subjects. Am Rev Respir Dis 141: 584-588, 1990.
135. Walter S, Nancy NR, Collier CR. Changes in the forced expiratory spirogram in young male smokers. Am Rev Respir Dis 119: 717-724, 1979.
136. Wang H, Liu X, Umino T, Skold CM, Zhu Y, Kohyama T, Spurzem JR, Romberger DJ, Rennard SI. Cigarette smoke inhibits human bronchial epithelial cell repair processes. Am J Respir Cell Mol Biol 25: 772-779, 2001.
137. Wanner A, Salathe M, O’Riordan TG. Mucociliary clearance in the airways. Am J Respir Crit Care Med 154: 1868-1902, 1996.
138. Weibel ER. Morphometry of the Human Lung. New York: Academic, 1963.
139. Woolcock AJ, Vincent NJ, Macklem PT. Frequency dependence of compliance as a test for obstruction in the small airways. J Clin Invest 48: 1097-1106, 1969.
140. Wright JL, Lawson LM, Pare PD, Kennedy S, Wiggs B, Hogg JC. The detection of small airways disease. Am Rev Respir Dis 129: 989-994, 1984.
141. Yanai M, Sekizawa K, Ohrui T, Sasaki H, Takishima T. Site of airway obstruction in pulmonary disease: direct measurement of intrabronchial pressure. J Appl Physiol (1985) 72: 1016-1023, 1992.